Improving report of the ADAURA trial by distinguishing treatment-related adverse events from treatment-emergent adverse events and assessing independence of censoring in final disease-free survival analyses Reply

被引：0

作者：

Herbst, Roy S. ^{[1
,2
]}

Wu, Yi-Long ^{[3
,4
]}

Tsuboi, Masahiro ^{[5
]}

机构：

[1] Yale Sch Med, New Haven, CT 06520 USA

[2] Yale Canc Ctr, New Haven, CT 06510 USA

[3] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China

[4] Guangdong Acad Med Sci, Guangzhou, Peoples R China

[5] Natl Canc Ctr Hosp East, Dept Thorac Surg & Oncol, Kashiwa, Japan

来源：

关键词：

D O I：

10.1200/JCO.23.00887

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4318 / U168

页数：3